Submit Deal

ZYLA LIFE SCIENCES

Summary

Zyla Life Sciences produces and distributes pharmaceutical products. The Company offers medicines in the forms of sprays, capsules, and oral suspension. Zyla Life Sciences serves patients in the United States.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 85 M

Avg. Deal Size£ 85 M

Market Context

Senior Management

Todd Smith
CEO
E. Blair Clark-Schoeb
Senior Vice President
Timothy Walbert
Chairman

Sort

16 Mar 2020|United States|Pharmaceuticals

Target: ZYLA LIFE SCIENCES

Bidder: ASSERTIO THERAPEUTICS

7 Service Providers

3 Target | 4 Bidder

34 Dealmakers

18 Target | 16 Bidder

£ 85 M

Value